Prognostic impact of lymphocyte subpopulations in peripheral blood after hematopoietic stem cell transplantation for hematologic malignancies.
The detailed kinetics of cytomegalovirus-specific T cell responses after hematopoietic stem cell transplantation: 1 year follow-up data.
Allogeneic hematopoietic cell transplantation for lymphoma: baseline and posttransplant prognostic factors.
Clinical characteristics and outcomes of patients with chronic disseminated candidiasis who need adjuvant corticosteroid therapy.
Prognostic significance of recurrent additional chromosomal abnormalities in adult patients with Philadelphia chromosome-positive acute lymphoblastic leukemia.
Prospective Randomized Comparison of Idarubicin and High-Dose Daunorubicin in Induction Chemotherapy for Newly Diagnosed Acute Myeloid Leukemia.
Reduced-Intensity Conditioning with Busulfan, Fludarabine, and Antithymocyte Globulin for Hematopoietic Cell Transplantation from Unrelated or Haploidentical Family Donors in Patients with Acute Myeloid Leukemia in Remission.
Salvage therapy for acute chemorefractory leukemia by allogeneic stem cell transplantation: the Korean experience.
Alterations in the bone marrow microenvironment may elicit defective hematopoiesis: a comparison of aplastic anemia, chronic myeloid leukemia, and normal bone marrow.
An isolated cardiac relapse after allogeneic hematopoietic stem cell transplantation for acute lymphoblastic leukemia.
Biweekly dose-dense gemcitabine-oxaliplatin and dexamethasone for relapsed/refractory aggressive non-Hodgkin lymphoma: A multicenter, single-arm, phase II trial.
Clinical and histopathological analysis of 46 cases of cutaneous adverse reactions to imatinib
Diagnostic usefulness of dynamic changes of CMV-specific T-cell responses in predicting CMV infections in HCT recipients.
Differences of cytomegalovirus diseases between kidney and hematopoietic stem cell transplant recipients during preemptive therapy.
Donor-Derived Natural Killer Cell Infusion after Human Leukocyte Antigen?Haploidentical Hematopoietic Cell Transplantation in Patients with Refractory Acute Leukemia
Dynamic prognostic value of the revised international prognostic scoring system following pretransplant hypomethylating treatment in myelodysplastic syndrome.
Evaluation of parameters obtained from the Sysmex XN-2000 for predicting the recovery of the absolute neutrophil count and platelets after hematopoietic stem cell transplantation.
Non-myeloablative conditioning for lower-risk myelodysplastic syndrome with bone marrow blasts less than 5%―a feasibility study
Prospective validation of a novel dosing scheme for intravenous busulfan in adult patients undergoing hematopoietic stem cell transplantation.
A Phase II Trial of Fludarabine/Melphalan 100 Conditioning Therapy Followed by Allogeneic Hematopoietic Cell Transplantation for Patients With Lymphoma.
A prospective, multicenter phase II study of continuous infusion of FLAG for patients older than 60혻yr with resistant acute myeloid leukemia: a comparison with intensive younger patients' trial.
Immunophenotypic markers in adult acute lymphoblastic leukemia: the prognostic significance of CD20 and TdT expression.
JAK2 V617F, MPL, and CALR Mutations in Korean Patients with Essential Thrombocythemia and Primary Myelofibrosis.
Long-term follow-up of imatinib plus combination chemotherapy in patients with newly diagnosed Philadelphia chromosome-positive acute lymphoblastic leukemia.
Monosomal karyotype in acute myeloid leukemia and the role of allogeneic hematopoietic cell transplantation.
Nilotinib combined with multiagent chemotherapy for newly diagnosed Philadelphia-positive acute lymphoblastic leukemia.
Prognostic role of FEV1 for survival in bronchiolitis obliterans syndrome after allogeneic hematopoietic stem cell transplantation.
Reconstitution of lymphocyte subpopulations after hematopoietic stem cell transplantation: comparison of hematologic malignancies and donor types in event-free patients.
Restrictive chronic lung function decline after haematopoietic stem cell transplantation.
The efficacy of prophylactic azithromycin on bronchiolitis obliterans syndrome after hematopoietic stem cell transplantation.
VLA-4 and CXCR4 expression levels show contrasting prognostic impact (favorable and unfavorable, respectively) in acute myeloid leukemia.
Vascular endothelial growth factor receptor tyrosine kinase inhibitor (VEGFR-TKI) rechallenge for patients with metastatic renal cell carcinoma after treatment failure using both VEGFR-TKI and mTOR inhibitor.
A prospective longitudinal study evaluating the usefulness of the interferon-gamma releasing assay for predicting active tuberculosis in allogeneic hematopoietic stem cell transplant recipients.
Active surveillance for metastatic or recurrent renal cell carcinoma.
Allogeneic hematopoietic cell transplantation without total body irradiation from unrelated donor in adult patients with idiopathic aplastic anemia: fludarabine versus cyclophosphamide-ATG.
CD34 and p53 immunohistochemical stains differentiate hypocellular myelodysplastic syndrome (hMDS) from aplastic anemia and a CD34 immunohistochemical stain provides useful survival information for hMDS.
Changes in the diffusion capacity for carbon monoxide and the development of non-infectious pneumonitis in patients with metastatic renal cell carcinoma treated with everolimus.
Clinical outcome after failure of hypomethylating therapy for myelodysplastic syndrome.
Donor-derived natural killer cells infused after human leukocyte antigen-haploidentical hematopoietic cell transplantation: a dose-escalation study.
Efficacy and safety of everolimus in korean patients with metastatic renal cell carcinoma following treatment failure with a vascular endothelial growth factor receptor-tyrosine kinase inhibitor.
Feasible outcomes of T cell-replete haploidentical stem cell transplantation with reduced-intensity conditioning in patients with myelodysplastic syndrome.
Preferential occurrence of spliceosome mutations in acute myeloid leukemia with preceding myelodysplastic syndrome and/or myelodysplasia morphology.
RANBP2-ALK fusion combined with monosomy 7 in acute myelomonocytic leukemia.
Reduced expression of osteonectin and increased natural killer cells may contribute to the pathophysiology of aplastic anemia.
Up-front allogeneic hematopoietic cell transplantation in acute myeloid leukemia arising from the myelodysplastic syndrome.
Upfront allogeneic hematopoietic cell transplantation in acute myeloid leukemia arising from myelodysplastic syndrome
Hepatic sinusoidal obstruction syndrome after allogeneic hematopoietic stem cell transplantation in adult patients with idiopathic aplastic anemia.
Prognostic implications of CD14 positivity in acute myeloid leukemia arising from myelodysplastic syndrome.
A Combination of CD15/CD10, CD64/CD33, CD16/CD13 or CD11b Flow Cytometric Granulocyte Panels is Sensitive and Specific for Diagnosis of Myelodysplastic Syndrome.
A randomized comparison of cyclophosphamide vs. reduced dose cyclophosphamide plus fludarabine for allogeneic hematopoietic cell transplantation in patients with aplastic anemia and hypoplastic myelodysplastic syndrome
A rare case of Lennert’s type peripheral T-cell lymphoma with t(14;19)(q11.2;q13.3)
Application of an immune-magnetic cell sorting method for CD138-positive plasma cells in FISH analysis of multiple myeloma
Association of cup-like nuclei in blasts with FLT3 and NPM1 mutations in acute myeloid leukemia.
Blastic plasmacytoid dendritic cell neoplasm: a single-center experience.
Bone marrow findings of 23 Korean post-transplant lymphoproliferative disorder patients: a single-center experience
Clinical features of adult patients with secondary hemophagocytic lymphohistiocytosis from causes other than lymphoma: an analysis of treatment outcome and prognostic factors
Comparison of the QuantiFERON-TB Gold In-Tube test with the tuberculin skin test for detecting latent tuberculosis infection prior to hematopoietic stem cell transplantation.
Efficacy and safety of low-dose ganciclovir preemptive therapy in allogeneic haematopoietic stem cell transplant recipients compared with conventional-dose ganciclovir: a prospective observational study.
Feasibility of hypomethylating agents followed by allogeneic hematopoietic cell transplantation in patients with myelodysplastic syndrome.
Flow cytometric quantification and immunophenotyping of leukemic stem cells in acute myeloid leukemia.
Generation of lymphocytes potentiated against leukemic lymphoblasts by stimulation using leukemic cell lysate-pulsed dendritic cells in patients with acute lymphoblastic leukemia and measurement of in vitro anti-leukemic cytotoxicity
Simplified flow cytometric immunophenotyping panel for multiple myeloma, CD56/CD19/CD138(CD38)/CD45, to differentiate neoplastic myeloma cells from reactive plasma cells
Two cycles of the PS-341/bortezomib, adriamycin, and dexamethasone combination followed by autologous hematopoietic cell transplantation in newly diagnosed multiple myeloma patients
A prediction model for complete remission upon reinduction for patients with acute myeloid leukemia after failure of anthracycline and cytarabine standard chemotherapy.
A randomized trial comparing standard versus high-dose daunorubicin induction in patients with acute myeloid leukemia.
Clinical Implications of Non-A-Type NPM1 and FLT3 Mutations in Patients with Normal Karyotype Acute Myeloid Leukemia.
Clinical effect of reduced-intensity conditioning regimen containing antithymocyte globulin for hematopoietic cell transplantation from unrelated-donors.
Comparison between Matched Related and Alternative Donors of Allogeneic Hematopoietic Stem Cells Transplanted into Adult Patients with Acquired Aplastic Anemia: Multivariate and Propensity Score-Matched Analysis.
High prevalence of hepatitis Band hepatitis C virus infection in Korean patients with hematopoietic malignancies.
Influence of GST gene polymorphisms on the clearance of intravenous busulfan in adult patients undergoing hematopoietic cell transplantation.
Paradoxical rising cytomegalovirus antigenemia during preemptive ganciclovir therapy in hematopoietic stem cell transplant recipients: incidence, risk factors, and clinical outcomes.
Pre-engraftment graft-versus-host disease after allogeneic hematopoietic cell transplantation for acute leukemia.
Prognostic significance of the FLT3 ITD mutation in patients with normal-karyotype acute myeloid leukemia in relapse.
Randomized Trial of Postoperative Adjuvant Therapy in Stage II and III Rectal Cancer to Defi ne the Optimal Sequence of Chemotherapy and Radiotherapy: 10-Year Follow-Up.
Randomized trial of postoperative adjuvant therapy in stage II and III rectal cancer to define the optimal sequence of chemotherapy and radiotherapy: 10-year follow up.
Reduced-intensity conditioning therapy with busulfan, fludarabine, and anti-thymocyte globulin for HLA-haploidentical hamatopoietic celltransplantation in acute leukemia and myelodysplastic syndrome.
Reduced-intensity conditioning therapy with busulfan, fludarabine, and anti-thymocyte globulin for HLA-haploidentical hematopoietic cell transplantation in acute leukemia and myelodysplastic syndrome.
Retrospective multicenter study on the development of peripheral lymphocytosis following second-line dasatinib therapy for chronic myeloid leukemia.
Single nucleotide polymorphism of Wilms' tumor 1 gene rs16754 in Korean patients with cytogenetically normal acute myeloid leukemia
Single nucleotide polymorphism of Wilms' tumor 1 gene rs16754 in Korean patients with cytogenetically normal acute myeloid leukemia.
Acute promyelocytic leukemia occuring in a previously healthy bone marrow donor.
Allogeneic hematopoietic cell transplantation for acute leukemia in first relapse or second remission.
Allogeneic hematopoietic cell transplantation for myelodysplastic syndrome:prognostic significance of pre-transplant IPSS score and comorbidity.
Clinical and radiological features of invasive pulmonary aspergillosis in transplant recipients and neutropenic patients.
Decreased incidence of febrile episodes with antibiotic prophylaxis in the treatment of decitabine for myelodysplastic syndrome.
High prevalence of hepatitis B and hepatitis C virus infections in Korean patients with hematopoietic malignancies.
Influence of Environmental Conditions on c-Jun N-terminal Kinase Mediated Apoptosis of HL60 Cells by Anti-Cancer Drugs.
Minimal Residual Disease Detection in Acute Leukemia Patients by Flow Cytometric Assay of Cross-lineage Antigen Expression.
Minimal residual disease detection in acute leukemia patients by flow cytometric assay of cross-lineage antigen expression
Outcome of attempted Hickman catheter salvage in febrile neutropenic cancer patients with Staphylococcus aureus bacteremia.
Phase IV study evaluating efficacy of escalated dose of imatinib in chronic myeloid leukemia patients showing suboptimal response to standard dose imatinib.
Predictive factors of poor prognosis in cancer patients with chemotherapy-induced febrile neutropenia.
Rosacea-like eruption associated with nilotinib.
Significance of fibrinogen, D-dimer, and LDH levels in predicting the risk of bleeding in patients with acute promyelocytic leukemia.
Therapy-related acute leukemia in breast cancer patients:twelve cases treated with a topoisomerase inhibitor.
Allogeneic hematopoietic cell transplantation for myelodysplastic syndrome: prognostic significance of pretransplant IPSS score and comorbidity.
Comparison of various criteria in predicting treatment response and prognosis of patients with myelodysplastic syndrome treated with azacitidine.
Hematopoietic cell transplantation from an HLA-mismatched familial donor is feasible without ex vivo-T cell depletion after reduced-intensity conditioning with busulfan, fludarabine, and antithymocyte globulin.
Reevaluation of the National Institutes of Health criteria for classification and scoring of chronic GVHD.
Single-dose mitoxantrone in combination with continuous infusion intermediate-dose cytarabine plus etoposide for treatment of refractory or early relapsed acute myeloid leukemia.
중심정맥관 관련 Tsukamurella pulmonis 균혈증 1예
Primary Granulocytic Sarcoma with Multiple Organ Involvement
급성전골수구성백혈병에서 PML/RARα 유전자 이형의 임상적 의의
A Case of Chronic Neutrophilic Leukemia with Multiple Myeloma and an Increased Function of Her Neutrophils
Hematologic and Clinical Features of 3q21q26 Syndrome: Extremely Poor Prognosis and Association with Central Diabetes Insipidus
Randomized comparison of four-times-daily versus once-daily intravenous busulfan in conditioning therapy for hematopoietic cell transplantation
Relationship between In Vitro Chemosensitivity assessed with MTT Assay and Clinical Outcomes in 103 Patients with Acute Leukemia
한방 약제의 장기 복용 후에 발생한 가역성 재생불량성빈혈 2예
Continuous infusion intermediate-dose cytarabine, mitoxantrone, plus etoposide for refractory or early relapsed acute myelogenous leukemia.
Erythroleukemic Blast Crisis of Chronic Myeloid Leukemia
Inferior prognostic outcome in acute promyelocytic leukemia with alterations of FLT3 gene.
Nonleukemic Granulocytic Sarcoma in the Bile Duct: A Case Report
Prognostic significance og MDR1, MRP and LRP mRNA expression in acute leukemia
Recommendation of the use of myeloblast percentage among non-erythroid cells instead of percentage among total nucleated cells for therapeutic response assessment in acute erythroid leukemia.
Risk score model for fatal intracranial hemorrhage in acute leukemia
Standard induction chemotherapy followed by attenuated consolidation in elderly patients with acute myeloid leukemia.
급성신부전에서 저용량의 All-trans Retinoic Acid로 관해유도에 성공한 급성전골수성 백혈병 1예.
조혈모세포이식시 조혈모세포의 체외 증폭능과 생착 소요시간간의 역상관 관계
An Improved Outlook for Patients with Acute Leukemia over the Last 14 Years - A Perspective from a University Hospital
Anti-leukemic effect of graft-versus-host disease on bone marrow and extramedullary relapses in acute leukemia
Clinical effect of imatinib added to intensive combination chemotherapy for newly diagnosed Philadelphia chromosome-positive acute lymphoblastic leukemia
Decreased incidence of hepatic veno-occlusive disease and fewer hemostatic derangements associated with intravenous busulfan vs oral busulfan in adults conditioned with busulfan + cyclophosphamide for allogeneic bone marrow transplantation
Morbidity and non-relapse mortality after allogeneic bone marrow transplantation in adult leukemia patients conditioned with busulfan plus cyclophosphamide: a retrospective comparison of oral versus intravenous busulfan
Prognostic factors identifiable at the time of onset of acute graft-versus-host disease after allogeneic hematopoietic cell transplantation
Prognostic significance of Fas (CD95) and TRAIL receptors (DR4/DR5) expression in acute myelogenous leukemia
한국인 만성골수성백혈병 환자의 imatinib (ST1-571) 내성 및 BCR-ABL 유전자 돌연변이 검출.
호염기구양 과립을 함유한 급성전골수구성백혈병 1예.
Analysis of fatal intracranial hemorrhage in 792 acute leukemia patients
Cyclosporine alone vs cyclosporine plus methotrexate for post-transplant immunosuppression after HLA-identical sibling bone marrow transplantation: a randomized prospective study
Failure of trilineage blood cell reconstitution after initial neutrophil engraftment in patients undergoing allogeneic hematopoietic cell transplantation - frequency and outcomes
Leptomeningeal carcinomatosis in gastric cancer
한국인 골수 이형성 증후군 환자들에 대한 FAB 분류와 WHO 분류의 비교 및 WHO 분류의 유효성
WHO 분류에 따른 골수섬유화를 동반한 급성범골수증식증 1례
Randomized Trial of Postoperative Adjuvant therapy in Stage II and III Rectal Cancer to Define the Optimal Sequence of Chemotherapy and Radiotherapy: A Preliminary Report
비전형 만수골수성백혈병 4예
Lung Complications After Allogenic Bone Marrow Transplantation
급성백혈병에서 다약제내성 기능적 측정법 확립 및 다약제내성 활성도와 함암제 치료 결과의 상관성
Prognostic value of hematopoietic chimerism in patients with acute leukemia after allogeneic bone marrow transplanation: a prospective study
급성백혈명에서 다약제내성 기능적 측정법 확립 및 다약제내성 활성도와 항암제 치료 결과의 상관성
Veno-occlusive disease of the liver after allogeneic bone marrow transplantation for severe aplastic anemia
Sezary 증후군 1례.
Prognostic value of DNA flow cytometry in stomach cancer: a 5-year prospective study
본태성 혈소판증다증에서 거핵구의 핵 고수성과 혈소판 응집능 검사의 의의
수술 후 보조항암화학요법을 실시한 유방암 환자의 생존 및 예후인자 분석
성인 급성림프아구성 백혈병에서 philadelphia염색체와 BCR-ABL 재배열 분석
수술후 보조항암 화학요법을 실시한 유방암 환자의 생존 및 예후인자 분석
Prospective Study on Success and Complication Rate of Central Venous Catheterization in a University - affiliated Hospital
국소적 식도암의 복합치료시 예후인자로서 p53 단백 과발현이 완전반응과 생존에 미치는 영향
심판막 질환에 병발한 혈소판의 알파-저장푸울 결핍증 1례
인체 제대혈 내의 조혈세포양 및 HLA 분포 : 제대혈은행 설립을 위한 기초 조사
급성 전골수성 백혈병의 치료후 골수소견과 치료반응 지표
국소적 식도암에서 선행화학요법과 방사선 병행 치료후 수술을 하는 복합치료의 효과
Hyperfractionated Radiotherapy and Concurrent Chemotherapy for Stage III Unresectable Non Small Cell Lung Cancer : Preliminary Report for Response and Toxicity
Hyperfractionated Radiotherapy and Concurrent Chemotherapy for Stage III Unreasectabel Non Small Cell Lung Cancer : Preliminary Report for Response and Toxicity
Preoperative Chemoradiotherapy for Locoregional Esophageal Cancer Preliminary
비소세포성 페암의 수술 후 MVP복합 화학요법과 방사선병용 치료 결과
비소세포성 폐암의 수술후 MVP 복합화학요법과 방사선 병용치료 결과
악성조직구증의 임상상 25례
철결핍성 및 만성질병성 빈혈에서 Zinc Protoporphyrin의 측정
Hyperfractionated Radiotherapy Following Induction Chemotherapy for Stage Ⅲ Non-Small Cell Lung Cancer-Random iced for Adjuvant Chemotherapy vs. Observation-
Hyperfractionated Radiotherapy Following InductionChemotherapy for Stage III Non-Small Cell Lung Cancer
Mitomycin C, Vinblastine, and Cisplatin(MVP) Combination Chemotherapy for Advanced Non-Small Cell Lung Cancer
Cystic Lymphangioma of the Spleen
MVP Chemotherpy and Hyperfractionated Radiotherapy for Stage Ⅲ Unresectable Non-Small Cell Lung Cancer –Randomized for maintenance Chemotherapy vs. Observation; Preliminary Report
MVP chemotherapy and Hyperfractionated Radiotherapy for Stage III Unresectable Non-Small Cell Lung Cancer
The Analysis of Failure Pattern in Locally Advanced Stomach Cancer Treated with Surgery and Post-Op Chemotherapy; To Explore The Role of Post-Op Irradiation
단독요법의 치료효과: Piperacillin-amikin 병합요법과의 무작위 비교